Latest News
-
Two nose cells likely Covid-19 entry points
Two specific cell types in the nose have been identified as likely initial infection points for Covid-19, according to a study published last night. Read more
-
Action of key tuberculosis drug identified
British scientists say they have found how a key drug can kill the tuberculosis bacterium, potentially paving the way for the development of new therapies. Read more
-
Uterine cancer-driving mutations occur early in life
An insight into the earliest stages of uterine cancer has been revealed after British scientists discovered cancer-driving mutations that often arise early in life. Read more
-
Is a peptide the answer to antibiotic resistance?
A peptide could be the answer to halting antibiotic resistance, according to a Swedish study. Read more
-
Covid-19 antiviral drug trial unsuccessful – but vaccine trials launched
British doctors are to begin clinical trials of a vaccine against Covid-19 infection tomorrow – as trials of antiviral medicines continued to prove disappointing. Read more
-
Decoy protein could halt Covid-19
Scientists are developing decoy proteins that bind and trap the coronavirus to stop it infecting cells, it has been announced. Read more
-
German and UK parents most anti-vaccinations
One in 30 parents in Germany and the UK are anti-vaccinations regardless of which disease they are for, according to a new study. Read more
-
Transfer of drug-resistant microbes between pets and humans ‘minimal’
Pets are not a major source of transmission of drug-resistant microbes to the owners, according to a study prepared for a cancelled European conference. Read more
-
EU cancer death rate predictions published
Death rates from prostate cancer are predicted to fall across the EU and in the UK – except in Poland, according to predictions published today. Read more
-
AI to aid Covid-19 planning
Trials have begun of a system that will use machine learning to help predict the demand for ICU beds and ventilators during the pandemic. Read more